Mucosal trafficking of vector-specific CD4+ T lymphocytes following vaccination of rhesus monkeys with adenovirus serotype 5. - Wikidata - wikimedia - TriplyDB

Mucosal trafficking of vector-specific CD4+ T lymphocytes following vaccination of rhesus monkeys with adenovirus serotype 5.

Mucosal trafficking of vector-specific CD4+ T lymphocytes following vaccination of rhesus monkeys with adenovirus serotype 5.

http://www.wikidata.org/entity/Q34120780

about

Induction of intestinal immunity by mucosal vaccines as a means of controlling HIV infection Decreased pre-existing Ad5 capsid and Ad35 neutralizing antibodies increase HIV-1 infection risk in the Step trial independent of vaccination Adenoviral vectors as novel vaccines for influenza.Human immunodeficiency virus vaccine trials Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individuals Antibody persistence and T-cell balance: two key factors confronting HIV vaccine development.Increase in DNA vaccine efficacy by virosome delivery and co-expression of a cytolytic protein.Induction of HIV-1-specific mucosal immune responses following intramuscular recombinant adenovirus serotype 26 HIV-1 vaccination of humans Interleukin-encoding adenoviral vectors as genetic adjuvant for vaccination against retroviral infection Heterologous prime-boost regimens with a recombinant chimpanzee adenoviral vector and adjuvanted F4 protein elicit polyfunctional HIV-1-specific T-Cell responses in macaques.Durable mucosal simian immunodeficiency virus-specific effector memory T lymphocyte responses elicited by recombinant adenovirus vectors in rhesus monkeys DNA/NYVAC vaccine regimen induces HIV-specific CD4 and CD8 T-cell responses in intestinal mucosa.TRIM5α does not affect simian immunodeficiency virus SIV(mac251) replication in vaccinated or unvaccinated Indian rhesus macaques following intrarectal challenge exposure Sexual risk behaviors, circumcision status, and preexisting immunity to adenovirus type 5 among men who have sex with men participating in a randomized HIV-1 vaccine efficacy trial: step study Accelerated heterologous adenovirus prime-boost SIV vaccine in neonatal rhesus monkeys.Adenovirus serotype 26 utilizes CD46 as a primary cellular receptor and only transiently activates T lymphocytes following vaccination of rhesus monkeys.Risk of immunodeficiency virus infection may increase with vaccine-induced immune response.Mucosal vaccination with a live recombinant rhinovirus followed by intradermal DNA administration elicits potent and protective HIV-specific immune responses.Modeling pre-existing immunity to adenovirus in rodents: immunological requirements for successful development of a recombinant adenovirus serotype 5-based ebola vaccine.Adenovirus serotype 26 and 35 vectors induce simian immunodeficiency virus-specific T lymphocyte responses in foreskin in rhesus monkeys.HIV-specific CD4 T cells and immune control of viral replication.HIV vaccines: a brief overview.Adenovirus-vectored Ebola vaccines.A dendritic cell targeted vaccine induces long-term HIV-specific immunity within the gastrointestinal tract.The two faces of vaccine-induced immune response: protection or increased risk of HIV infection?!Vaccination with recombinant adenovirus expressing peste des petits ruminants virus-F or -H proteins elicits T cell responses to epitopes that arises during PPRV infection.Conserved HIV Epitopes for an Effective HIV Vaccine.

P2860

Q27001897-EE87B720-B32B-4338-ADAF-73978CFA757C Q28730757-6A2A62F9-7797-4DFD-9EF8-9554624FFE83 Q30370445-D0CBD135-76B4-49FE-A7F7-4D51DABAA217 Q30424366-0E1154C8-E3A4-4389-9315-9AE94B8BDDB2 Q34218500-DF3BB460-E9D8-44A1-9E0F-064BCADE55FF Q34480617-36D74A77-C3BF-4F64-9CB8-99EABCA5ED4E Q34511631-22CF134A-0ED7-4506-AF09-57AD177719E1 Q35055188-D3C9A518-6044-4041-A860-0A20914246C2 Q35070346-1E415B72-0E0E-412A-BDAD-CF68AFB04B2F Q35344875-C5936B9F-7CD1-4551-923E-B8AE1A804B76 Q35363320-F95944B3-7AF5-4378-ABB0-A5E7298B14C6 Q35382338-5C742664-CFE5-4678-A943-F79C21604C64 Q35531415-168B99CF-8A96-4B31-BCF8-EB9EF9341BB7 Q36084253-FA622CF3-0C91-4D2A-B59D-003E9E7B4002 Q36171869-F30DC5B6-87AC-4B91-9516-254A2C26BAA0 Q36276518-48567B1F-382A-4217-8600-C349141C1D34 Q36276637-F8D391B9-E09E-4736-A1F6-61D4C1D2A7D5 Q37419985-C5B7DAF9-C5E0-4FCD-A21F-E1C315C425B3 Q37627897-9A85F283-7C19-4A71-919E-EB15EE70AF6E Q37713545-62F07CDF-1103-4625-8B04-97CADFAD3407 Q37866624-DA7AF61D-922F-426B-BDFB-DC0CFF6B52B7 Q38210557-7F060EDF-547B-4D0B-9940-1179F6DEF729 Q38569831-C1C6337A-9659-42EA-A3C8-22D6E4055629 Q40844843-566A2748-E25F-483A-AD37-C6492FDFA71A Q42241791-A2ABFFD1-34FA-42E7-948A-BD9E495FCC04 Q45324559-ED764A7E-D755-439B-8ADE-4A5D43D316E7 Q47093684-8D77A308-B20F-4162-A047-EE53A1785EBE

P2860

Mucosal trafficking of vector-specific CD4+ T lymphocytes following vaccination of rhesus monkeys with adenovirus serotype 5.

http://www.wikidata.org/entity/Q34120780

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Mucosal trafficking of vector- ...... ys with adenovirus serotype 5.

@ast

Mucosal trafficking of vector- ...... ys with adenovirus serotype 5.

@en

Mucosal trafficking of vector- ...... ys with adenovirus serotype 5.

@nl

type

label

Mucosal trafficking of vector- ...... ys with adenovirus serotype 5.

@ast

Mucosal trafficking of vector- ...... ys with adenovirus serotype 5.

@en

Mucosal trafficking of vector- ...... ys with adenovirus serotype 5.

@nl

prefLabel

Mucosal trafficking of vector- ...... ys with adenovirus serotype 5.

@ast

Mucosal trafficking of vector- ...... ys with adenovirus serotype 5.

@en

Mucosal trafficking of vector- ...... ys with adenovirus serotype 5.

@nl

P1433

Q34120780-F457FA5C-CC89-42DA-8DF9-BEAB2250426F

P1476

Q34120780-6D589244-BDE7-4AAD-8E7B-3AF591FA5FCA

P2093

Q34120780-2719BAAB-BCB9-495F-90DE-559EBCE4856E

Q34120780-5101B7CB-DD26-4507-BAB5-8ABF4A8E4DB7

Q34120780-6F40EEC7-AA66-4311-943D-157533ED6CEB

Q34120780-C857563D-2885-46B4-9264-C2CE0A9EDD85

Q34120780-CA47FCD0-45DF-4CEE-98F3-F952A0B44B7A

Q34120780-CF283161-5119-4DA2-9AAC-591D2BDF09FA

Q34120780-EEA2E4A5-1153-427B-83E6-4C85936DF689

Q34120780-FF0B47B5-F0F3-406A-911C-02048E656FE1

P2860

Q34120780-2ACDF0BB-65E0-4F8C-A5DF-1F609F68A425

Q34120780-49C6FE4E-050C-4637-93DC-B3EE73C2531D

Q34120780-9993E8CD-251D-42CC-A336-FCF5E3818D8B

Q34120780-A55B61D8-3D16-4EBD-AFA7-008CC9EE9001

Q34120780-B2DEA3CF-CE92-4610-9291-7F73B3F7334D

Q34120780-CBB5C6E1-051C-4885-A3AA-D2030A669C14

Q34120780-D5BBAA69-E915-4BE3-BD31-C5C7588E4F2B

Q34120780-DB6B3CCC-68EE-4310-9A8C-0483352EB85C

Q34120780-EAB2133A-34C8-4964-9D29-E83A013F86EB

P304

Q34120780-4D11DBC3-9A25-4CC7-B4A4-6E1F475C212A

P31

Q34120780-AF9F61B3-BF63-46D3-8105-170CFF8638FB

P356

Q34120780-E2C27492-F1F6-4956-A545-2EEEA87B3F8F

P407

Q34120780-73961D6C-8B42-494F-8D1F-7B347BB9DE64

P433

Q34120780-878CB38F-8C74-4A93-A174-A4F949444A42

P478

Q34120780-46BD84CE-4CCA-41A4-8E7E-A985049BDCB5

P50

Q34120780-46AFA5AF-B5EC-44C1-8C6A-4603730108D6

Q34120780-BE28105F-E507-48E4-8BD6-F4D9298EEAAA

P577

Q34120780-A03B35DA-A376-432D-8975-6796D1B85A2A

P698

Q34120780-623BF2A7-6AEF-44F3-80F1-D6631792017E

P921

Q34120780-4C4B67B6-1D79-4572-BBE6-9622A92C5BA3

P932

Q34120780-A676BBA0-0EA0-40B3-AE6C-F45491A5CF74

P356

P1433

Journal of Virology

P1476

Mucosal trafficking of vector- ...... ys with adenovirus serotype 5.

@en

P2093

Angela Carville

http://www.w3.org/2001/XMLSchema#string

Annalena La Porte

http://www.w3.org/2001/XMLSchema#string

Hualin Li

http://www.w3.org/2001/XMLSchema#string

James B Whitney

http://www.w3.org/2001/XMLSchema#string

Jinyan Liu

http://www.w3.org/2001/XMLSchema#string

Kara L O'Brien

http://www.w3.org/2001/XMLSchema#string

Katherine Masek-Hammerman

http://www.w3.org/2001/XMLSchema#string

Keith G Mansfield

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

Localization of Simian immunodeficiency virus-infected cells in the genital tract of male and female Rhesus macaques.

Potential HIV-1 target cells in the human penis.

Activation of a dendritic cell-T cell axis by Ad5 immune complexes creates an improved environment for replication of HIV in T cells

Baseline Ad5 serostatus does not predict Ad5 HIV vaccine-induced expansion of adenovirus-specific CD4+ T cells.

Human immunodeficiency virus-1 acquisition in genital mucosa: Langerhans cells as key-players.

Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humans.

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis.

Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1.

P304

9810-9816

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.01157-10

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-08-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20686023

http://www.w3.org/2001/XMLSchema#string

P921

P932

2937774

http://www.w3.org/2001/XMLSchema#string